David Shook is Chief Medical Officer of Lyell Immunopharma, Inc.. Currently has a direct ownership of 21,900 shares of LYEL, which is worth approximately $212,211. The most recent transaction as insider was on Jun 09, 2025, when has been sold 21,900 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.9K
n/a 3M change
n/a 12M change
Total Value Held $212,211

David Shook Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 09 2025
BUY
Grant, award, or other acquisition
-
21,900 Added 50.0%
21,900 Common Stock

Also insider at

NKTX
Nkarta, Inc. Healthcare
DS

David Shook

Chief Medical Officer
South San Francisco, CA

Track Institutional and Insider Activities on LYEL

Follow Lyell Immunopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LYEL shares.

Notify only if

Insider Trading

Get notified when an Lyell Immunopharma, Inc. insider buys or sells LYEL shares.

Notify only if

News

Receive news related to Lyell Immunopharma, Inc.

Track Activities on LYEL